Method of treating ocular diseases by periocular administration of cyclosporine A or G
AssigneeThe Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
InventorsRobert B. Nussenblatt, Alan G. Palestine
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treating ocular diseases by the administration of cyclosporine A or G by periocular injection in a pharmaceutically acceptable carrier.
Claims16
A method for treating ocular disease which comprises administering to a patient by periocular injection cyclosporine G in a pharmaceutically acceptable carrier in an amount effective for treating ocular disease.
A method for treating ocular disease which comprises administering to a patient by periocular injection cyclosporine A in a pharmaceutically acceptable carrier in an amount effective for treating ocular disease.
A method for treating ocular disease which comprises administering to a patient by periocular injection cyclosporine G in a pharmaceutically acceptable carrier, wherein the cyclosporine G is administered in an amount of from 10 to 100 mg/ml in a medically suitable vehicle.
A method for treating ocular disease which comprises administering to a patient by periocular injection cyclosporine A in a pharmaceutically acceptable carrier, wherein the cyclosporine A is administered in an amount of from 10 to 100 mg/ml in a medically suitable vehicle.
A pharmaceutical composition for treating ocular disease which comprises cyclosporine G or A and a pharmaceutical carrier suitable for periocular injection.
Dependencies are inferred from the claim text.